These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36941622)

  • 41. Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study.
    Ma C; Meng K; Shi S; Zhao T; Chen S; Zhou X; Shu R; Ma M; Tian M; Ding J
    Eur J Med Res; 2023 Sep; 28(1):393. PubMed ID: 37773193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An analysis of the clinical features of lung cancer in patients with connective tissue diseases.
    Saijo A; Hanibuchi M; Goto H; Toyoda Y; Tezuka T; Nishioka Y
    Respir Investig; 2017 Mar; 55(2):153-160. PubMed ID: 28274531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
    Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
    BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rituximab in autoimmune connective tissue disease-associated interstitial lung disease.
    Sharp C; McCabe M; Dodds N; Edey A; Mayers L; Adamali H; Millar AB; Gunawardena H
    Rheumatology (Oxford); 2016 Jul; 55(7):1318-24. PubMed ID: 27060110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease-associated Interstitial Lung Disease.
    Algamdi M; Sadatsafavi M; Fisher JH; Morisset J; Johannson KA; Fell CD; Kolb M; Manganas H; Cox G; Gershon AS; Halayko AJ; Hambly N; Khalil N; Shapera S; To T; Wilcox PG; Guler S; Ryerson CJ
    Ann Am Thorac Soc; 2020 Sep; 17(9):1077-1084. PubMed ID: 32437249
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
    Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
    BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review.
    Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP
    Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases.
    Chiu YH; Spierings J; de Jong PA; Hoesein FM; Grutters JC; van Laar JM; Voortman M
    Respir Med; 2021 Oct; 187():106579. PubMed ID: 34438351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis.
    Koo BS; Park KY; Lee HJ; Kim HJ; Ahn HS; Yim SY; Jun JB
    Arthritis Res Ther; 2021 Apr; 23(1):100. PubMed ID: 33823923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Connective tissue disease--associated interstitial lung disease: an underreported cause of interstitial lung disease in Sub-Saharan Africa.
    Olaosebikan H; Adeyeye O; Akintayo R; Akpabio A; Adenitan A; Adelowo O; Ojo O; Abimbola FO
    Clin Rheumatol; 2021 Sep; 40(9):3455-3460. PubMed ID: 32803569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
    Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
    Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and prognostic features associated with anti-Ro52 autoantibodies in connective tissue diseases patients with interstitial lung disease.
    Shi X; Pu X; Cao D; Yan T; Ye Q
    Clin Exp Rheumatol; 2023 Nov; 41(11):2257-2263. PubMed ID: 37279146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience.
    Boutel M; Boutou A; Pitsiou G; Garyfallos A; Dimitroulas T
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease.
    Boerner EB; Cuyas M; Theegarten D; Ohshimo S; Costabel U; Bonella F
    Respiration; 2020; 99(8):628-636. PubMed ID: 32663826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human epididymis protein 4 is associated with severity and poor prognosis of connective tissue disease-associated interstitial lung disease with usual interstitial pneumonia pattern.
    Meng K; Tian M; Gui X; Xie M; Gao Y; Shi S; Zhao T; Xiao Y; Cai H; Ding J
    Int Immunopharmacol; 2022 Jul; 108():108704. PubMed ID: 35413677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
    Oldham JM; Lee C; Valenzi E; Witt LJ; Adegunsoye A; Hsu S; Chen L; Montner S; Chung JH; Noth I; Vij R; Strek ME
    Respir Med; 2016 Dec; 121():117-122. PubMed ID: 27888985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study.
    Ju C; Lian Q; Chen A; Xu X; Zhang J; Luo Q; Huang D; Chen R; He J
    Clin Exp Rheumatol; 2022 Sep; 40(9):1666-1673. PubMed ID: 34796840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on the Red Blood Cell Distribution Width in Connective Tissue Disease Associated with Interstitial Lung Disease.
    Liu C; Yang J; Lu Z
    Biomed Res Int; 2020; 2020():8130213. PubMed ID: 32047815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.
    Khanna D; Mittoo S; Aggarwal R; Proudman SM; Dalbeth N; Matteson EL; Brown K; Flaherty K; Wells AU; Seibold JR; Strand V
    J Rheumatol; 2015 Nov; 42(11):2168-71. PubMed ID: 25729034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
    Koo SM; Uh ST
    Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.